MedTrace Logo

Mechanisms of Immunosurveillance for Lung Cancer

NCT01710319 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2018-05-07

No results posted yet for this study

Summary

The purpose of this research study is to investigate the differences in "natural killer (NK) blood cells, a type of white blood cell that fights infection in the body, among different types of patients that have lung surgery. The four different groups of patients are:

* smokers with lung cancer
* smokers without lung cancer
* non-smokers with lung cancer
* non-smokers without lung cancer.

Conditions

Interventions

OTHER

blood draw

a blood specimen will be obtained from each patient in the four groups. An optional blood draw after 30 days of initial blood specimen if indicated.

Sponsors & Collaborators

  • Saint Louis VA Medical Center

    collaborator FED

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Alexander S Krupnick, MD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2016-07-07
Completion
2016-07-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01710319 on ClinicalTrials.gov